Filter (Type enter to validate)
  Cat_Number Product name Supplier Quantity Price Tech More
FRA901aNormal rat multiple organ frozen tissue array, for therapeutic and diagnostic antibody validation, 45 cases 45 cores, 2 slides set, replacing FRA901; ihc Anti-Actin confirmedUS Biomax858 FRA901a Normal rat multiple organ frozen tissue array, for therapeutic and diagnostic antibody validation, 45 cases 45 cores, 2 slides set, replacing FRA901; ihc Anti-Actin confirmed US Biomax 858
ASK
Publication
FRA901a-2Normal rat multiple organ frozen tissue array, for therapeutic and diagnostic antibody validation for FDA approval, 45 cases 45 cores, slide 2 of 2 tissue arrays, replacing FRA901-2; ihc Anti-Actin cUS Biomax626 FRA901a-2 Normal rat multiple organ frozen tissue array, for therapeutic and diagnostic antibody validation for FDA approval, 45 cases 45 cores, slide 2 of 2 tissue arrays, replacing FRA901-2; ihc Anti-Actin c US Biomax 626
ASK
Publication
FRA901a-1Normal rat multiple organ frozen tissue array, for therapeutic and diagnostic antibody validation for FDA approval, 45 cases 45 cores, slide 2 of 2 tissue arrays, replacing FRA901-1; ihc Anti-Actin cUS Biomax626 FRA901a-1 Normal rat multiple organ frozen tissue array, for therapeutic and diagnostic antibody validation for FDA approval, 45 cases 45 cores, slide 2 of 2 tissue arrays, replacing FRA901-1; ihc Anti-Actin c US Biomax 626
ASK
Publication
FMO901-2Normal mouse multiple organ frozen tissue array, for therapeutic and diagnostic antibody, 15 organs 45 cores, slide 2 of 2 tissue arrays; ihc Anti-Actin confirmedUS Biomax626 FMO901-2 Normal mouse multiple organ frozen tissue array, for therapeutic and diagnostic antibody, 15 organs 45 cores, slide 2 of 2 tissue arrays; ihc Anti-Actin confirmed US Biomax 626
ASK
Publication
FDA902-2FDA Standard Frozen Tissue Array, for therapeutic and diagnostic antibody validation for FDA approval, 15 cases 45 cores, replaced by FDA902b-2; ihc Anti-Actin confirmedUS Biomax858 FDA902-2 FDA Standard Frozen Tissue Array, for therapeutic and diagnostic antibody validation for FDA approval, 15 cases 45 cores, replaced by FDA902b-2; ihc Anti-Actin confirmed US Biomax 858
ASK
Publication
FDA901-2FDA Standard Frozen Tissue Array, for therapeutic and diagnostic antibody validation for FDA approval, total 30 organs, 3 individual donors per organ. (slide two); ihc Anti-Actin confirmedUS Biomax858 FDA901-2 FDA Standard Frozen Tissue Array, for therapeutic and diagnostic antibody validation for FDA approval, total 30 organs, 3 individual donors per organ. (slide two); ihc Anti-Actin confirmed US Biomax 858
ASK
Publication
FDA901-1FDA Standard Frozen Tissue Array, for therapeutic and diagnostic antibody validation for FDA approval, total 30 organs, 3 individual donors per organ. (slide one); ihc Anti-Actin confirmedUS Biomax858 FDA901-1 FDA Standard Frozen Tissue Array, for therapeutic and diagnostic antibody validation for FDA approval, total 30 organs, 3 individual donors per organ. (slide one); ihc Anti-Actin confirmed US Biomax 858
ASK
Publication
FDA902bFDA Standard Frozen Tissue Array (2 slide set), for therapeutic and diagnostic monoclonal antibody validation recommanded by FDA, 90 tissue cores of 30 organs, 3 individual donors per organ, replacingUS Biomax1206 FDA902b FDA Standard Frozen Tissue Array (2 slide set), for therapeutic and diagnostic monoclonal antibody validation recommanded by FDA, 90 tissue cores of 30 organs, 3 individual donors per organ, replacing US Biomax 1206
ASK
Publication
FDA901FDA Standard Frozen Tissue Array, for therapeutic and diagnostic antibody validation for FDA approval, total 30 organs, 3 individual donors per organ, spanning two frozen tissue microarray slides.; ihUS Biomax1438 FDA901 FDA Standard Frozen Tissue Array, for therapeutic and diagnostic antibody validation for FDA approval, total 30 organs, 3 individual donors per organ, spanning two frozen tissue microarray slides.; ih US Biomax 1438
ASK
Publication
FDA902aFDA Standard Frozen Tissue Array, for therapeutic and diagnostic antibody validation for FDA approval, total 30 organs, 3 individual donors per organ, spanning two frozen tissue microarray slides, repUS Biomax1206 FDA902a FDA Standard Frozen Tissue Array, for therapeutic and diagnostic antibody validation for FDA approval, total 30 organs, 3 individual donors per organ, spanning two frozen tissue microarray slides, rep US Biomax 1206
ASK
Publication
FMC402bMultiple organ cancer frozen tissue array, with normal tissue, including pathology grade, 40 cases 40 cores, replacing FMC402a; ihc Anti-Actin confirmedUS Biomax626 FMC402b Multiple organ cancer frozen tissue array, with normal tissue, including pathology grade, 40 cases 40 cores, replacing FMC402a; ihc Anti-Actin confirmed US Biomax 626
ASK
Publication
FMC409aFrozen multiple organ cancer tissue array, 20 cases 40 cores, replacing FMC409; ihc Anti-Actin confirmedUS Biomax626 FMC409a Frozen multiple organ cancer tissue array, 20 cases 40 cores, replacing FMC409; ihc Anti-Actin confirmed US Biomax 626
ASK
Publication
FDA902FDA Standard Frozen Tissue Array (2 slide set), for therapeutic and diagnostic monoclonal antibody validation recommanded by FDA, 90 tissue cores of 30 organs, 3 individual donors per organUS Biomax199 FDA902 FDA Standard Frozen Tissue Array (2 slide set), for therapeutic and diagnostic monoclonal antibody validation recommanded by FDA, 90 tissue cores of 30 organs, 3 individual donors per organ US Biomax 199
ASK
Publication
FMC407bMultiple organ cancer frozen tissue array, including TNM information, 40 cases 40 cores, replacing FMC407; ihc Anti-Actin confirmedUS Biomax626 FMC407b Multiple organ cancer frozen tissue array, including TNM information, 40 cases 40 cores, replacing FMC407; ihc Anti-Actin confirmed US Biomax 626
ASK
Publication
FRA781-2FDA standard normal rat multiple organ frozen tissue array, slide two, 26 cases 78 cores; ihc Anti-Actin confirmedUS Biomax626 FRA781-2 FDA standard normal rat multiple organ frozen tissue array, slide two, 26 cases 78 cores; ihc Anti-Actin confirmed US Biomax 626
ASK
Publication
FRA781-1FDA standard normal rat multiple organ frozen tissue array, slide one, 26 cases 78 cores; ihc Anti-Actin confirmedUS Biomax626 FRA781-1 FDA standard normal rat multiple organ frozen tissue array, slide one, 26 cases 78 cores; ihc Anti-Actin confirmed US Biomax 626
ASK
Publication
FBN407aMultiple organ normal frozen tissue array, 20 cases 40 cores, replaing FBN407; ihc Anti-Actin confirmedUS Biomax626 FBN407a Multiple organ normal frozen tissue array, 20 cases 40 cores, replaing FBN407; ihc Anti-Actin confirmed US Biomax 626
ASK
Publication
FMC282aMultiple organ cancer frozen tissue array, including pathology grade, 28 cases 28 cores, replacing FMC282; ihc Anti-Actin confirmedUS Biomax394 FMC282a Multiple organ cancer frozen tissue array, including pathology grade, 28 cases 28 cores, replacing FMC282; ihc Anti-Actin confirmed US Biomax 394
ASK
Publication
FMC405aMultiple organ cancer frozen tissue array, including pathology grade, 40 cases 40 cores, replacing FMC405; ihc Anti-Actin confirmedUS Biomax626 FMC405a Multiple organ cancer frozen tissue array, including pathology grade, 40 cases 40 cores, replacing FMC405; ihc Anti-Actin confirmed US Biomax 626
ASK
Publication
FBN401Normal human multiple organ frozen tissue array (20 organs in duplicate), 20 cases 40 cores; ihc Anti-Actin confirmedUS Biomax278 FBN401 Normal human multiple organ frozen tissue array (20 organs in duplicate), 20 cases 40 cores; ihc Anti-Actin confirmed US Biomax 278
ASK
Publication
FDA999aMultiple organ normal tissue array, 47 cases 99 cores, replacing FDA999; ihc Anti-Actin confirmedUS Biomax296 FDA999a Multiple organ normal tissue array, 47 cases 99 cores, replacing FDA999; ihc Anti-Actin confirmed US Biomax 296
ASK
Publication
BN1002aMultiple organ normal tissue array, 100 cases 100 cores, replacing BN1002; ihc Anti-Actin confirmedUS Biomax296 BN1002a Multiple organ normal tissue array, 100 cases 100 cores, replacing BN1002; ihc Anti-Actin confirmed US Biomax 296
ASK
Publication
FDA808a-1Multiple organ normal tissue array, 72 cases 72 cores, replacing FDA808-1; ihc Anti-Actin confirmedUS Biomax267 FDA808a-1 Multiple organ normal tissue array, 72 cases 72 cores, replacing FDA808-1; ihc Anti-Actin confirmed US Biomax 267
ASK
Publication
BN243aMultiple organ normal tissue array, 12 cases 24 cores, replacing BN243; ihc Anti-Actin confirmedUS Biomax105 BN243a Multiple organ normal tissue array, 12 cases 24 cores, replacing BN243; ihc Anti-Actin confirmed US Biomax 105
ASK
Publication
FRA901-2Normal rat multiple organ (recommended by FDA) frozen tissue array, slide two, 15 cases 45 cores, replaced by FRA901a-2; ihc Anti-Actin confirmedUS Biomax626 FRA901-2 Normal rat multiple organ (recommended by FDA) frozen tissue array, slide two, 15 cases 45 cores, replaced by FRA901a-2; ihc Anti-Actin confirmed US Biomax 626
ASK
Publication
FRA901-1FDA standard normal rat multiple organ frozen tissue array, slide one, 15 cases 45 cores, replaced by FRA901a-1; ihc Anti-Actin confirmedUS Biomax626 FRA901-1 FDA standard normal rat multiple organ frozen tissue array, slide one, 15 cases 45 cores, replaced by FRA901a-1; ihc Anti-Actin confirmed US Biomax 626
ASK
Publication
FMC402aMultiple organ cancer frozen tissue array, with normal tissue, including pathology grade, 40 cases 40 cores, replaced by FMC402b; ihc Anti-Actin confirmedUS Biomax626 FMC402a Multiple organ cancer frozen tissue array, with normal tissue, including pathology grade, 40 cases 40 cores, replaced by FMC402b; ihc Anti-Actin confirmed US Biomax 626
ASK
Publication
MC803aMultiple organ tumor tissue array with adjacent normal tissue, including TNM and clinical stage, 40 cases 80 cores, replacing MC803; ihc Anti-Actin confirmedUS Biomax320 MC803a Multiple organ tumor tissue array with adjacent normal tissue, including TNM and clinical stage, 40 cases 80 cores, replacing MC803; ihc Anti-Actin confirmed US Biomax 320
ASK
Publication
FBN406aMultiple organ normal frozen tissue array, 20 organs 40 cores; ihc Anti-Actin confirmedUS Biomax394 FBN406a Multiple organ normal frozen tissue array, 20 organs 40 cores; ihc Anti-Actin confirmed US Biomax 394
ASK
Publication
FFE302aMultiple organ normal frozen tissue array, 15 organs 30 cores; ihc Anti-Actin confirmedUS Biomax394 FFE302a Multiple organ normal frozen tissue array, 15 organs 30 cores; ihc Anti-Actin confirmed US Biomax 394
ASK
Publication
FRA781FDA standard normal rat multiple organ frozen tissue array, two slides, 26 cases 78 coresUS Biomax331 FRA781 FDA standard normal rat multiple organ frozen tissue array, two slides, 26 cases 78 cores US Biomax 331
ASK
Publication
BCN963aMultiple organ tumor and adjacent normal tissue array, including TNM, clinical stage and pathology grade, 81 cases 96 cores, replacing BCN963; ihc Anti-Actin confirmedUS Biomax258 BCN963a Multiple organ tumor and adjacent normal tissue array, including TNM, clinical stage and pathology grade, 81 cases 96 cores, replacing BCN963; ihc Anti-Actin confirmed US Biomax 258
ASK
Publication
FMO721FDA standard normal mouse multiple organ frozen tissue array, two slides, 24 cases 72 coresUS Biomax293 FMO721 FDA standard normal mouse multiple organ frozen tissue array, two slides, 24 cases 72 cores US Biomax 293
ASK
Publication
MC246Multiple organ tumor with matched adjacent normal tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing MC244; ihc Anti-Actin confirmedUS Biomax90 MC246 Multiple organ tumor with matched adjacent normal tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing MC244; ihc Anti-Actin confirmed US Biomax 90
ASK
Publication
FBN406Multiple organ normal frozen tissue array, 20 cases 40 cores, replacing FBN404US Biomax167 FBN406 Multiple organ normal frozen tissue array, 20 cases 40 cores, replacing FBN404 US Biomax 167
ASK
Publication
FFE302Multiple organ normal frozen tissue array, 15 cases 30 cores, replacing FFE301US Biomax199 FFE302 Multiple organ normal frozen tissue array, 15 cases 30 cores, replacing FFE301 US Biomax 199
ASK
Publication
FBN407Multiple organ normal frozen tissue array, 20 cases 40 cores, replacing FBN404US Biomax281 FBN407 Multiple organ normal frozen tissue array, 20 cases 40 cores, replacing FBN404 US Biomax 281
ASK
Publication
FDA808a-2Multiple organ tumor tissue array with adjacent normal human organs, including TNM, clinical stage and pathology grade, 72 cases 72 cores, replacing FDA808-2; ihc Anti-Actin confirmedUS Biomax267 FDA808a-2 Multiple organ tumor tissue array with adjacent normal human organs, including TNM, clinical stage and pathology grade, 72 cases 72 cores, replacing FDA808-2; ihc Anti-Actin confirmed US Biomax 267
ASK
Publication
FMC406cFrozen multiple human organ cancer tissue array, including TNM and clinical stage, 40 cases 40 cores; ihc Anti-Actin confirmedUS Biomax626 FMC406c Frozen multiple human organ cancer tissue array, including TNM and clinical stage, 40 cases 40 cores; ihc Anti-Actin confirmed US Biomax 626
ASK
Publication
CyFDA1FDA multiple organ normal tissue array of cynomolgus monkey, 34 organs 99 cores, replacing CyFDA; ihc Anti-Actin confirmedUS Biomax296 CyFDA1 FDA multiple organ normal tissue array of cynomolgus monkey, 34 organs 99 cores, replacing CyFDA; ihc Anti-Actin confirmed US Biomax 296
ASK
Publication
MBN481Multiple organ normal tissue array, 48 cases 48 cores; ihc Anti-Actin confirmedUS Biomax185 MBN481 Multiple organ normal tissue array, 48 cases 48 cores; ihc Anti-Actin confirmed US Biomax 185
ASK
Publication
MO541Mouse multiple organ normal tissue array, 24 cases 54 cores; ihc Anti-Actin confirmedUS Biomax162 MO541 Mouse multiple organ normal tissue array, 24 cases 54 cores; ihc Anti-Actin confirmed US Biomax 162
ASK
Publication
FMC281Multiple tumor and corresponding normal frozen tissue (14 types) array, 14 cases 28 cores, previously named FMC401; ihc Anti-Actin confirmedUS Biomax394 FMC281 Multiple tumor and corresponding normal frozen tissue (14 types) array, 14 cases 28 cores, previously named FMC401; ihc Anti-Actin confirmed US Biomax 394
ASK
Publication
BC01071aMultiple organ cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores, replacing BC01071; ihc Anti-Actin confirmedUS Biomax185 BC01071a Multiple organ cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores, replacing BC01071; ihc Anti-Actin confirmed US Biomax 185
ASK
Publication
MC6163High-density tissue array of multiple organ tumor and normal tissue, with pathology grade, cllinical stage and TNM, 616 cases 616 cores; ihc Anti-Actin confirmedUS Biomax811 MC6163 High-density tissue array of multiple organ tumor and normal tissue, with pathology grade, cllinical stage and TNM, 616 cases 616 cores; ihc Anti-Actin confirmed US Biomax 811
ASK
Publication
FDA807FDA normal and tumor organ tissue array of human (2 slide set), replacing FDA806, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies; ihc Anti-Actin confirmedUS Biomax296 FDA807 FDA normal and tumor organ tissue array of human (2 slide set), replacing FDA806, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies; ihc Anti-Actin confirmed US Biomax 296
ASK
Publication
FDA808aFDA normal and tumor organ tissue array of human (2 slide set), replacing FDA808, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies; ihc Anti-Actin confirmedUS Biomax296 FDA808a FDA normal and tumor organ tissue array of human (2 slide set), replacing FDA808, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies; ihc Anti-Actin confirmed US Biomax 296
ASK
Publication
FDA808FDA normal and tumor organ tissue array of human (2 slide set), replacing FDA807, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies; ihc Anti-Actin confirmedUS Biomax296 FDA808 FDA normal and tumor organ tissue array of human (2 slide set), replacing FDA807, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies; ihc Anti-Actin confirmed US Biomax 296
ASK
Publication
ME241aMultiple malignant melanoma tissue array with adjacent normal skin tissue, including TNM and clinical stage, 12 cases 24 cores, replacing ME241; ihc Anti-Actin confirmedUS Biomax105 ME241a Multiple malignant melanoma tissue array with adjacent normal skin tissue, including TNM and clinical stage, 12 cases 24 cores, replacing ME241; ihc Anti-Actin confirmed US Biomax 105
ASK
Publication
HN803aMultiple head and neck cancer tissue array with normal tissue, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing HN803; ihc Anti-Actin confirmedUS Biomax296 HN803a Multiple head and neck cancer tissue array with normal tissue, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing HN803; ihc Anti-Actin confirmed US Biomax 296
ASK
Publication
FMC409Multiple organ cancer frozen tissue array, 20 cases 40 cores replacing FMC401US Biomax281 FMC409 Multiple organ cancer frozen tissue array, 20 cases 40 cores replacing FMC401 US Biomax 281
ASK
Publication
FDG281fNormal dog multiple organ frozen tissue array, 28 cases 28 coresUS Biomax199 FDG281f Normal dog multiple organ frozen tissue array, 28 cases 28 cores US Biomax 199
ASK
Publication
FBN404Multiple organ normal frozen tissue array, 20 cases 40 coresUS Biomax167 FBN404 Multiple organ normal frozen tissue array, 20 cases 40 cores US Biomax 167
ASK
Publication
FDG281mNormal male dog multiple organ frozen tissue array, 28 cases 28 coresUS Biomax199 FDG281m Normal male dog multiple organ frozen tissue array, 28 cases 28 cores US Biomax 199
ASK
Publication
FMC402Multiple organ cancer frozen tissue array, with normal tissue 40 cases 40 coresUS Biomax91 FMC402 Multiple organ cancer frozen tissue array, with normal tissue 40 cases 40 cores US Biomax 91
ASK
Publication
FRA901Normal rat multiple organ (recommended by FDA) frozen tissue array, slide one, 15 cases 45 coresUS Biomax331 FRA901 Normal rat multiple organ (recommended by FDA) frozen tissue array, slide one, 15 cases 45 cores US Biomax 331
ASK
Publication
FRB281mNormal male rabbit multiple organ frozen tissue array, 28 cases 28 coresUS Biomax293 FRB281m Normal male rabbit multiple organ frozen tissue array, 28 cases 28 cores US Biomax 293
ASK
Publication
FRB281fNormal female rabbit multiple organ frozen tissue array, 28 cases 28 coresUS Biomax293 FRB281f Normal female rabbit multiple organ frozen tissue array, 28 cases 28 cores US Biomax 293
ASK
Publication
MC964Multiple organ tumor tissue array, including TNM, clinical stage and pathology grade, for testing tumor tissue specificity of therapeutic antibodies, 96 cases 96 cores, replacing MC961US Biomax266 MC964 Multiple organ tumor tissue array, including TNM, clinical stage and pathology grade, for testing tumor tissue specificity of therapeutic antibodies, 96 cases 96 cores, replacing MC961 US Biomax 266
ASK
Publication
BRF401Breast cancer frozen tissue array, with normal tissue, 40 cases 40 cores, Her-2 and ER PR IHC are supplied when purchase; ihc Anti-Actin confirmedUS Biomax742 BRF401 Breast cancer frozen tissue array, with normal tissue, 40 cases 40 cores, Her-2 and ER PR IHC are supplied when purchase; ihc Anti-Actin confirmed US Biomax 742
ASK
Publication
BR01015Multiple organ, normal tissue array, 8 normal tissues, 160 cases 160 cores, replacing BR01011US Biomax278 BR01015 Multiple organ, normal tissue array, 8 normal tissues, 160 cases 160 cores, replacing BR01011 US Biomax 278
ASK
Publication
BN00119Multiple organ normal tissue array, 40 cases 40 cores, replacing BN00112US Biomax266 BN00119 Multiple organ normal tissue array, 40 cases 40 cores, replacing BN00112 US Biomax 266
ASK
Publication
BN126Multiple organ normal tissue array, replacing BN113, 45 cases 45 coresUS Biomax231 BN126 Multiple organ normal tissue array, replacing BN113, 45 cases 45 cores US Biomax 231
ASK
Publication
FDA999Multiple organ normal tissue array, 47 cases 99 cores, replacing FDA998US Biomax314 FDA999 Multiple organ normal tissue array, 47 cases 99 cores, replacing FDA998 US Biomax 314
ASK
Publication
BN1002Multiple organ (20) normal tissue array, 100 cases 100 cores, replacing BN1001US Biomax266 BN1002 Multiple organ (20) normal tissue array, 100 cases 100 cores, replacing BN1001 US Biomax 266
ASK
Publication
BN129Multiple organ adjacent normal tissue array, 48 cases 48 cores, replacing BN116US Biomax160 BN129 Multiple organ adjacent normal tissue array, 48 cases 48 cores, replacing BN116 US Biomax 160
ASK
Publication
MC244Multiple organ cancer and normal adjacent tissue array, replacing MC241, 12 cases 24 coresUS Biomax88 MC244 Multiple organ cancer and normal adjacent tissue array, replacing MC241, 12 cases 24 cores US Biomax 88
ASK
Publication
T203aLymphatic tissue tumor test tissue array, with normal control tissue, 12 cases 24 cores, replacing T203; ihc Anti-Actin confirmedUS Biomax90 T203a Lymphatic tissue tumor test tissue array, with normal control tissue, 12 cases 24 cores, replacing T203; ihc Anti-Actin confirmed US Biomax 90
ASK
Publication
LM482aLymphoma tissue array with normal lymph node tissue as control, 48 cases 48 cores, replacing LM482; ihc Anti-Actin confirmedUS Biomax320 LM482a Lymphoma tissue array with normal lymph node tissue as control, 48 cases 48 cores, replacing LM482; ihc Anti-Actin confirmed US Biomax 320
ASK
Publication
MS481aMesothelioma tissue array with normal tissue as control, including TNM and clinical stage, 24 cases 48 cores, replacing MS481; ihc Anti-Actin confirmedUS Biomax296 MS481a Mesothelioma tissue array with normal tissue as control, including TNM and clinical stage, 24 cases 48 cores, replacing MS481; ihc Anti-Actin confirmed US Biomax 296
ASK
Publication
MC5002High density multiple organ tumor tissue array, with adjacent normal tissue, information of TNM, stage and grade, 500 cases 500 cores, replacing MC5001US Biomax634 MC5002 High density multiple organ tumor tissue array, with adjacent normal tissue, information of TNM, stage and grade, 500 cases 500 cores, replacing MC5001 US Biomax 634
ASK
Publication
LM801aLymphoma tissue array with adjacent normal lymph node and spleen tissue as control, 80 cases 80 cores, replacing LM801; ihc Anti-Actin confirmedUS Biomax267 LM801a Lymphoma tissue array with adjacent normal lymph node and spleen tissue as control, 80 cases 80 cores, replacing LM801; ihc Anti-Actin confirmed US Biomax 267
ASK
Publication
T231aTestis tumor tissue array with normal tissue as control, including TNM and clinical stage, 6 cases 24 cores, replacing T231; ihc Anti-Actin confirmedUS Biomax90 T231a Testis tumor tissue array with normal tissue as control, including TNM and clinical stage, 6 cases 24 cores, replacing T231; ihc Anti-Actin confirmed US Biomax 90
ASK
Publication
PRF281Prostate cancer frozen tissue array, with grade and Gleason scores and normal prostate tissue control, 28 cases 28 cores; ihc H&E and Anti-Actin confirmedUS Biomax742.35 PRF281 Prostate cancer frozen tissue array, with grade and Gleason scores and normal prostate tissue control, 28 cases 28 cores; ihc H&E and Anti-Actin confirmed US Biomax 742.35
ASK
Publication
MC641Multiple organ cancer and adjacent normal tissue array, including TNM and pathology grade, 59 cases 64 cores, replacing BC00115US Biomax0 MC641 Multiple organ cancer and adjacent normal tissue array, including TNM and pathology grade, 59 cases 64 cores, replacing BC00115 US Biomax 0
ASK
Publication
BCN963Multiple organ cancer and adjacent normal tissue array, including TNM and pathology grade, 78 cases 96 cores, replacing BCN961US Biomax266 BCN963 Multiple organ cancer and adjacent normal tissue array, including TNM and pathology grade, 78 cases 96 cores, replacing BCN961 US Biomax 266
ASK
Publication
MC5003High density multiple organ tumor and normal tissue array, with TNM and pathology grade, 500 cases 500 cores, replacing MC5002US Biomax634 MC5003 High density multiple organ tumor and normal tissue array, with TNM and pathology grade, 500 cases 500 cores, replacing MC5002 US Biomax 634
ASK
Publication
ME803aMalignant melanoma tissue array with adjacent normal skin tissue, including TNM and clinical stage, 80 cases 80 cores, replacing ME803; ihc Anti-Actin confirmedUS Biomax296 ME803a Malignant melanoma tissue array with adjacent normal skin tissue, including TNM and clinical stage, 80 cases 80 cores, replacing ME803; ihc Anti-Actin confirmed US Biomax 296
ASK
Publication
T045cLung cancer test tissue array, with normal control tissue, including TNM and pathology grade, 12 cases 24 cores, replacing T045; ihc Anti-Actin confirmedUS Biomax90 T045c Lung cancer test tissue array, with normal control tissue, including TNM and pathology grade, 12 cases 24 cores, replacing T045; ihc Anti-Actin confirmed US Biomax 90
ASK
Publication
MC809aBlastoma tissue array with normal tissue as control, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing MC809; ihc Anti-Actin confirmedUS Biomax382 MC809a Blastoma tissue array with normal tissue as control, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing MC809; ihc Anti-Actin confirmed US Biomax 382
ASK
Publication
T001aEmbryonal tumor test tissue array, with normal tissue as control, including TNM and clinical stage, 6 cases 24 cores, replacing T001; ihc Anti-Actin confirmedUS Biomax90 T001a Embryonal tumor test tissue array, with normal tissue as control, including TNM and clinical stage, 6 cases 24 cores, replacing T001; ihc Anti-Actin confirmed US Biomax 90
ASK
Publication
OV701Ovary cancer tissue array, with adjacent normal tissue, including TNM, clinical stage and pathology grade, 70 cases 70 cores, replacing BC111110; ihc Anti-Actin confirmedUS Biomax228 OV701 Ovary cancer tissue array, with adjacent normal tissue, including TNM, clinical stage and pathology grade, 70 cases 70 cores, replacing BC111110; ihc Anti-Actin confirmed US Biomax 228
ASK
Publication
T212aSkin tumor tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T212; ihc Anti-Actin confirmedUS Biomax90 T212a Skin tumor tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T212; ihc Anti-Actin confirmed US Biomax 90
ASK
Publication
PA242aPancreas cancer tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing PA242; ihc Anti-Actin confirmedUS Biomax105 PA242a Pancreas cancer tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing PA242; ihc Anti-Actin confirmed US Biomax 105
ASK
Publication
MC961Multiple organ cancer tissue array for testing tumor tissue specificity of therapeutic antibodies, 96 cases 96 cores, replaced by MC964US Biomax231 MC961 Multiple organ cancer tissue array for testing tumor tissue specificity of therapeutic antibodies, 96 cases 96 cores, replaced by MC964 US Biomax 231
ASK
Publication
LV8010Liver cancer and normal tissue array, with stage and grade info, 80 cases 80 cores, replacing BC03011; ihc Anti-Actin confirmedUS Biomax296 LV8010 Liver cancer and normal tissue array, with stage and grade info, 80 cases 80 cores, replacing BC03011; ihc Anti-Actin confirmed US Biomax 296
ASK
Publication
FDA807-2Multiple organ tumor tissue array with adjacent normal human organs, including TNM and pathology grade, 72 cases 72 cores, replacing FDA806 2US Biomax336 FDA807-2 Multiple organ tumor tissue array with adjacent normal human organs, including TNM and pathology grade, 72 cases 72 cores, replacing FDA806 2 US Biomax 336
ASK
Publication
MCN602Multiple organ tumor and adjacent normal tissue array, including TNM, clinical stage and pathology grade, 58 cases 60 cores, replacing MCN601US Biomax231 MCN602 Multiple organ tumor and adjacent normal tissue array, including TNM, clinical stage and pathology grade, 58 cases 60 cores, replacing MCN601 US Biomax 231
ASK
Publication
FDA808-2Multiple organ tumor tissue array with adjacent normal human organs, including TNM and pathology grade, 72 cases 72 cores, replacing FDA805 2US Biomax277 FDA808-2 Multiple organ tumor tissue array with adjacent normal human organs, including TNM and pathology grade, 72 cases 72 cores, replacing FDA805 2 US Biomax 277
ASK
Publication
T112aOvary cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T112; ihc Anti-Actin confirmedUS Biomax90 T112a Ovary cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T112; ihc Anti-Actin confirmed US Biomax 90
ASK
Publication
T173aBrain cancer test tissue array, with normal tissue as control, including TNM and pathology grade, 2 serial sections, 6 cases 24 cores, replacing T173; ihc Anti-Actin confirmedUS Biomax90 T173a Brain cancer test tissue array, with normal tissue as control, including TNM and pathology grade, 2 serial sections, 6 cases 24 cores, replacing T173; ihc Anti-Actin confirmed US Biomax 90
ASK
Publication
PA805aPancreas cancer tissue array with adjacent normal tissue as control, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing PA805; ihc Anti-Actin confirmedUS Biomax296 PA805a Pancreas cancer tissue array with adjacent normal tissue as control, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing PA805; ihc Anti-Actin confirmed US Biomax 296
ASK
Publication
GL803aBrain tumor and adjacent normal tissue array, including pathology grade, 80 cases 80 cores, replacing GL803; ihc Anti-Actin confirmedUS Biomax296 GL803a Brain tumor and adjacent normal tissue array, including pathology grade, 80 cases 80 cores, replacing GL803; ihc Anti-Actin confirmed US Biomax 296
ASK
Publication
ME481aMelanoma tissue array with normal skin tissues, including TNM and clinical stage, 48 cases 48 cores, replacing ME481; ihc Anti-Actin confirmedUS Biomax185 ME481a Melanoma tissue array with normal skin tissues, including TNM and clinical stage, 48 cases 48 cores, replacing ME481; ihc Anti-Actin confirmed US Biomax 185
ASK
Publication
TH809aThyroid metastatic carcinoma tissue array with normal thyroid tissue as control, 40 cases 80 cores, replacing TH809; ihc Anti-Actin confirmedUS Biomax296 TH809a Thyroid metastatic carcinoma tissue array with normal thyroid tissue as control, 40 cases 80 cores, replacing TH809; ihc Anti-Actin confirmed US Biomax 296
ASK
Publication
T087aBreast cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores, replacing T087; ihc Anti-Actin confirmedUS Biomax90 T087a Breast cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores, replacing T087; ihc Anti-Actin confirmed US Biomax 90
ASK
Publication
OR601aOral squamous cell cancer tissue array with adjacent normal tongue tissue, including TNM, clinical stage and pathology grade, 60 cases 60 cores, replacing OR601; ihc Anti-Actin confirmedUS Biomax258 OR601a Oral squamous cell cancer tissue array with adjacent normal tongue tissue, including TNM, clinical stage and pathology grade, 60 cases 60 cores, replacing OR601; ihc Anti-Actin confirmed US Biomax 258
ASK
Publication
ST2091Stomach cancer tissue array with adjacent normal stomach tissue, including TNM and clinical stage, 208 cases 208 cores, replacing ST2001; ihc Anti-Actin confirmedUS Biomax487 ST2091 Stomach cancer tissue array with adjacent normal stomach tissue, including TNM and clinical stage, 208 cases 208 cores, replacing ST2001; ihc Anti-Actin confirmed US Biomax 487
ASK
Publication
LC10010aLung carcinoma tissue array with normal lung tissue as control, including TNM and clinical stage, 50 cases 100 cores, replacing LC10010; ihc Anti-Actin confirmedUS Biomax296 LC10010a Lung carcinoma tissue array with normal lung tissue as control, including TNM and clinical stage, 50 cases 100 cores, replacing LC10010; ihc Anti-Actin confirmed US Biomax 296
ASK
Publication
T175Brain tumor tissue array with normal brain tissue as control, including pathology grade, 12 cases 24 cores, replacing T172; ihc Anti-Actin confirmedUS Biomax105 T175 Brain tumor tissue array with normal brain tissue as control, including pathology grade, 12 cases 24 cores, replacing T172; ihc Anti-Actin confirmed US Biomax 105
ASK
Publication
CO802aColon cancer tissue array with adjacent normal colon tissue, including TNM and clinical stage, 80 cases 80 cores, replacing CO802; ihc Anti-Actin confirmedUS Biomax258 CO802a Colon cancer tissue array with adjacent normal colon tissue, including TNM and clinical stage, 80 cases 80 cores, replacing CO802; ihc Anti-Actin confirmed US Biomax 258
ASK
Publication
T174aBrain tumor tissue array with normal brain tissue as control, including pathology grade, 6 cases 24 cores, replacing T171; ihc Anti-Actin confirmedUS Biomax90 T174a Brain tumor tissue array with normal brain tissue as control, including pathology grade, 6 cases 24 cores, replacing T171; ihc Anti-Actin confirmed US Biomax 90
ASK
Publication
GL241aBrain tumor tissue array with adjacent normal brain tissue, including pathology grade, 10 cases 24 cores, replacing GL241; ihc Anti-Actin confirmedUS Biomax90 GL241a Brain tumor tissue array with adjacent normal brain tissue, including pathology grade, 10 cases 24 cores, replacing GL241; ihc Anti-Actin confirmed US Biomax 90
ASK
Publication
FMO901FDA standard normal mouse multiple organ frozen tissue array, slide one, 15 organs 45 coresUS Biomax293 FMO901 FDA standard normal mouse multiple organ frozen tissue array, slide one, 15 organs 45 cores US Biomax 293
ASK
Publication
FRB901FDA standard normal rabbit multiple organ frozen tissue array, slide one, 15 organs 45 coresUS Biomax331 FRB901 FDA standard normal rabbit multiple organ frozen tissue array, slide one, 15 organs 45 cores US Biomax 331
ASK
Publication
BC041115aLung cancer tissue array with normal lung tissue, including TNM, clinical stage and pathology grade, 120 cases 120 cores, replacing BC041115; ihc Anti-Actin confirmedUS Biomax296 BC041115a Lung cancer tissue array with normal lung tissue, including TNM, clinical stage and pathology grade, 120 cases 120 cores, replacing BC041115; ihc Anti-Actin confirmed US Biomax 296
ASK
Publication
ST801aStomach cancer tissue array with matched adjacent normal stomach tissue, including TNM and clinical stage, 40 cases 80 cores, replacing ST801; ihc Anti-Actin confirmedUS Biomax267 ST801a Stomach cancer tissue array with matched adjacent normal stomach tissue, including TNM and clinical stage, 40 cases 80 cores, replacing ST801; ihc Anti-Actin confirmed US Biomax 267
ASK
Publication
PA961aPancreatic cancer tissue array with normal pancreatic tissue, including TNM, clinical stage and pathology grade, 96 cases 96 cores, replacing PA961; ihc Anti-Actin confirmedUS Biomax258 PA961a Pancreatic cancer tissue array with normal pancreatic tissue, including TNM, clinical stage and pathology grade, 96 cases 96 cores, replacing PA961; ihc Anti-Actin confirmed US Biomax 258
ASK
Publication
OV241aOvary cancer and adjacent normal tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing OV241; ihc Anti-Actin confirmedUS Biomax105 OV241a Ovary cancer and adjacent normal tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing OV241; ihc Anti-Actin confirmed US Biomax 105
ASK
Publication
T054aColon cancer tissue array with normal colon tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T054; ihc Anti-Actin confirmedUS Biomax90 T054a Colon cancer tissue array with normal colon tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T054; ihc Anti-Actin confirmed US Biomax 90
ASK
Publication
PR243aProstate cancer tissue array with adjacent normal prostate tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing PR243; ihc Anti-Actin confirmedUS Biomax105 PR243a Prostate cancer tissue array with adjacent normal prostate tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing PR243; ihc Anti-Actin confirmed US Biomax 105
ASK
Publication
BR243eBreast cancer tissue array with adjacent normal breast tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replacing BR243a; ihc Anti-Actin confirmedUS Biomax90 BR243e Breast cancer tissue array with adjacent normal breast tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replacing BR243a; ihc Anti-Actin confirmed US Biomax 90
ASK
Publication
CO241aColon cancer tissue array with adjacent normal colon tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replacing CO241; ihc Anti-Actin confirmedUS Biomax105 CO241a Colon cancer tissue array with adjacent normal colon tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replacing CO241; ihc Anti-Actin confirmed US Biomax 105
ASK
Publication
PR242aProstate cancer tissue array with adjacent normal prostate tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing PR242; ihc Anti-Actin confirmedUS Biomax105 PR242a Prostate cancer tissue array with adjacent normal prostate tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing PR242; ihc Anti-Actin confirmed US Biomax 105
ASK
Publication
BRN801aBreast adjacent normal tissue array with breast cancer tissue, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing BRN801; ihc Anti-Actin confirmedUS Biomax258 BRN801a Breast adjacent normal tissue array with breast cancer tissue, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing BRN801; ihc Anti-Actin confirmed US Biomax 258
ASK
Publication
CO484aColon cancer tissue array with adjacent normal tissues, including TNM, clinical stage and pathology grade, 48 cases 48 cores, replacing CO484; ihc Anti-Actin confirmedUS Biomax210 CO484a Colon cancer tissue array with adjacent normal tissues, including TNM, clinical stage and pathology grade, 48 cases 48 cores, replacing CO484; ihc Anti-Actin confirmed US Biomax 210
ASK
Publication
CO242aColon carcinoma tissue array with adjacent normal colon tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing CO242; ihc Anti-Actin confirmedUS Biomax81 CO242a Colon carcinoma tissue array with adjacent normal colon tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing CO242; ihc Anti-Actin confirmed US Biomax 81
ASK
Publication
BR243fBreast cancer tissue array with matched adjacent normal breast tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replacing BR243a; ihc Anti-Actin confirmedUS Biomax90 BR243f Breast cancer tissue array with matched adjacent normal breast tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replacing BR243a; ihc Anti-Actin confirmed US Biomax 90
ASK
Publication
BR243dBreast cancer tissue array with matched adjacent normal breast tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replacing BR243c; ihc Anti-Actin confirmedUS Biomax90 BR243d Breast cancer tissue array with matched adjacent normal breast tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replacing BR243c; ihc Anti-Actin confirmed US Biomax 90
ASK
Publication
BC05118aColon cancer tissue array with matched adjacent normal colon tissue, including TNM, clinical stage and pathology grade, 50 cases 100 cores, replacing BC05118; ihc Anti-Actin confirmedUS Biomax296 BC05118a Colon cancer tissue array with matched adjacent normal colon tissue, including TNM, clinical stage and pathology grade, 50 cases 100 cores, replacing BC05118; ihc Anti-Actin confirmed US Biomax 296
ASK
Publication
BR243bBreast invasive ductal carcinoma tissue array with matched adjacent normal breast tissue, including TNM and pathology grade, 6 cases 24 cores, replacing BR243; ihc Anti-Actin confirmedUS Biomax90 BR243b Breast invasive ductal carcinoma tissue array with matched adjacent normal breast tissue, including TNM and pathology grade, 6 cases 24 cores, replacing BR243; ihc Anti-Actin confirmed US Biomax 90
ASK
Publication
FMC408Multiple organ cancer frozen tissue array, including TNM and clinical stage, 40 cases 40 coresUS Biomax167 FMC408 Multiple organ cancer frozen tissue array, including TNM and clinical stage, 40 cases 40 cores US Biomax 167
ASK
Publication
FMC405Multiple organ carcinoma frozen tissue array, including TNM and clinical stage, 40 cases 40 coresUS Biomax167 FMC405 Multiple organ carcinoma frozen tissue array, including TNM and clinical stage, 40 cases 40 cores US Biomax 167
ASK
Publication
FMC407Multiple organ cancer frozen tissue array, including TNM and clinical stage, 40 cases 40 coresUS Biomax331 FMC407 Multiple organ cancer frozen tissue array, including TNM and clinical stage, 40 cases 40 cores US Biomax 331
ASK
Publication
T113aOvary cancer test tissue array with normal ovary tissue, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores, replacing T113; ihc Anti-Actin confirmedUS Biomax90 T113a Ovary cancer test tissue array with normal ovary tissue, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores, replacing T113; ihc Anti-Actin confirmed US Biomax 90
ASK
Publication
CO243aColon carcinoma tissue array with matched adjacent normal colon tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing CO243; ihc Anti-Actin confirmedUS Biomax105 CO243a Colon carcinoma tissue array with matched adjacent normal colon tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing CO243; ihc Anti-Actin confirmed US Biomax 105
ASK
Publication
LN802Multiple organ lymph tissue array, 80 cases 80 cores, replacing LN801US Biomax231 LN802 Multiple organ lymph tissue array, 80 cases 80 cores, replacing LN801 US Biomax 231
ASK
Publication
FDA805-2Multiple organ cancer and 6 types of normal organ tissue array, including TNM and pathology grade, 72 cases 72 cores, replaced by FDA808 2US Biomax278 FDA805-2 Multiple organ cancer and 6 types of normal organ tissue array, including TNM and pathology grade, 72 cases 72 cores, replaced by FDA808 2 US Biomax 278
ASK
Publication
HN241aHead and neck cancer tissue array with adjacent normal head and neck tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing HN241; ihc Anti-Actin confirmedUS Biomax90 HN241a Head and neck cancer tissue array with adjacent normal head and neck tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing HN241; ihc Anti-Actin confirmed US Biomax 90
ASK
Publication
BN117Multiple organ normal tissue array, 45 cases 45 coresUS Biomax189 BN117 Multiple organ normal tissue array, 45 cases 45 cores US Biomax 189
ASK
Publication
BN00015Multiple organ normal tissue array, 47 cases 48 coresUS Biomax160 BN00015 Multiple organ normal tissue array, 47 cases 48 cores US Biomax 160
ASK
Publication
BN484Multiple organ normal tissue array, 24 cases 48 coresUS Biomax231 BN484 Multiple organ normal tissue array, 24 cases 48 cores US Biomax 231
ASK
Publication
BN00011Multiple organ normal tissue array, 48 cases 48 coresUS Biomax160 BN00011 Multiple organ normal tissue array, 48 cases 48 cores US Biomax 160
ASK
Publication
BN115Multiple organ normal tissue array, 46 cases 46 coresUS Biomax189 BN115 Multiple organ normal tissue array, 46 cases 46 cores US Biomax 189
ASK
Publication
NHL802aNon-Hodgkin's lymphoma tissue array, 42 cases 80 cores, replacing NHL802; ihc Anti-Actin confirmedUS Biomax267 NHL802a Non-Hodgkin's lymphoma tissue array, 42 cases 80 cores, replacing NHL802; ihc Anti-Actin confirmed US Biomax 267
ASK
Publication
BE01015Multiple organ, normal fetus tissue array, 50 cases 50 coresUS Biomax189 BE01015 Multiple organ, normal fetus tissue array, 50 cases 50 cores US Biomax 189
ASK
Publication
BE01014Multiple organ, normal fetus tissue array, 26 cases 78 coresUS Biomax189 BE01014 Multiple organ, normal fetus tissue array, 26 cases 78 cores US Biomax 189
ASK
Publication
BN114Multiple normal human organ tissue array, 48 cases 48 coresUS Biomax189 BN114 Multiple normal human organ tissue array, 48 cases 48 cores US Biomax 189
ASK
Publication
BC00114Multiple organ normal and diseased tissue array, 36 cases 60 coresUS Biomax231 BC00114 Multiple organ normal and diseased tissue array, 36 cases 60 cores US Biomax 231
ASK
Publication
MC542Multiple organ diseased tissue array, including TNM and pathology grade, 54 cases 54 cores, replacing MC541US Biomax160 MC542 Multiple organ diseased tissue array, including TNM and pathology grade, 54 cases 54 cores, replacing MC541 US Biomax 160
ASK
Publication
MC631Multiple organ, diseased tissue array (63 cases 63 cores, 20 types of cancer and disease), replacing BC00014US Biomax160 MC631 Multiple organ, diseased tissue array (63 cases 63 cores, 20 types of cancer and disease), replacing BC00014 US Biomax 160
ASK
Publication
FDA800Multiple organ tumor tissue array, 72 cases of variety of cancers 72 cores, replacing FDA802 2 or FDA803 2US Biomax266 FDA800 Multiple organ tumor tissue array, 72 cases of variety of cancers 72 cores, replacing FDA802 2 or FDA803 2 US Biomax 266
ASK
Publication
MC962Multiple carcinoma tissue array with matched normal organ tissue, 58 cases 96 coresUS Biomax0 MC962 Multiple carcinoma tissue array with matched normal organ tissue, 58 cases 96 cores US Biomax 0
ASK
Publication
GL806aBrain glioblastoma multiforme(GBM) tissue array, 40 cases 80 cores, replacing GL806; ihc Anti-Actin confirmedUS Biomax258 GL806a Brain glioblastoma multiforme(GBM) tissue array, 40 cases 80 cores, replacing GL806; ihc Anti-Actin confirmed US Biomax 258
ASK
Publication
BN113Multiple organ normal tissue array, replaced by BN126, 45 cases 45 coresUS Biomax189 BN113 Multiple organ normal tissue array, replaced by BN126, 45 cases 45 cores US Biomax 189
ASK
Publication
BC00432Multiple organ tumor and adjacent normal tissue array, 39 cases 43 coresUS Biomax160 BC00432 Multiple organ tumor and adjacent normal tissue array, 39 cases 43 cores US Biomax 160
ASK
Publication
BN116Multiple organ normal tissue array, 48 cases 48 cores, replaced by BN129US Biomax189 BN116 Multiple organ normal tissue array, 48 cases 48 cores, replaced by BN129 US Biomax 189
ASK
Publication
TMA2001Multiple organ cancer with normal tissue array, with TNM data, 180 cases 200 coresUS Biomax397 TMA2001 Multiple organ cancer with normal tissue array, with TNM data, 180 cases 200 cores US Biomax 397
ASK
Publication
T0013Multiple organ cancer test tissue array, with normal tissue, including TNM and pathology grade, 6 cases 24 coresUS Biomax88 T0013 Multiple organ cancer test tissue array, with normal tissue, including TNM and pathology grade, 6 cases 24 cores US Biomax 88
ASK
Publication
T009Multiple organ cancer test tissue array, with normal tissue, including TNM and pathology grade, 6 cases 24 coresUS Biomax88 T009 Multiple organ cancer test tissue array, with normal tissue, including TNM and pathology grade, 6 cases 24 cores US Biomax 88
ASK
Publication
T0012Multiple organ cancer test tissue array, with normal tissue, including TNM and pathology grade, 6 cases 24 coresUS Biomax88 T0012 Multiple organ cancer test tissue array, with normal tissue, including TNM and pathology grade, 6 cases 24 cores US Biomax 88
ASK
Publication
T008Multiple organ cancer test tissue array, with normal tissue, including TNM and pathology grade, 6 cases 24 coresUS Biomax88 T008 Multiple organ cancer test tissue array, with normal tissue, including TNM and pathology grade, 6 cases 24 cores US Biomax 88
ASK
Publication
T0011Multiple organ cancer test tissue array, with normal tissue, including TNM and pathology grade, 6 cases 24 coresUS Biomax88 T0011 Multiple organ cancer test tissue array, with normal tissue, including TNM and pathology grade, 6 cases 24 cores US Biomax 88
ASK
Publication
T007Multiple organ cancer test tissue array, with normal tissue, including TNM and pathology grade, 6 cases 24 coresUS Biomax88 T007 Multiple organ cancer test tissue array, with normal tissue, including TNM and pathology grade, 6 cases 24 cores US Biomax 88
ASK
Publication
T0010Multiple organ cancer test tissue array, with normal tissue, including TNM and pathology grade, 6 cases 24 coresUS Biomax88 T0010 Multiple organ cancer test tissue array, with normal tissue, including TNM and pathology grade, 6 cases 24 cores US Biomax 88
ASK
Publication
T0014Multiple organ cancer test tissue array, with normal tissue, including TNM and pathology grade, 6 cases 24 coresUS Biomax88 T0014 Multiple organ cancer test tissue array, with normal tissue, including TNM and pathology grade, 6 cases 24 cores US Biomax 88
ASK
Publication
LY121aDiffuse large B-cell lymphoma tissue array, 12 cases 12 cores, replacing LY121; ihc Anti-Actin confirmedUS Biomax185 LY121a Diffuse large B-cell lymphoma tissue array, 12 cases 12 cores, replacing LY121; ihc Anti-Actin confirmed US Biomax 185
ASK
Publication
NHL401aLymphoma, myeloma and lymph node tissue array, 40 cases 40 cores, replacing NHL401; ihc Anti-Actin confirmedUS Biomax296 NHL401a Lymphoma, myeloma and lymph node tissue array, 40 cases 40 cores, replacing NHL401; ihc Anti-Actin confirmed US Biomax 296
ASK
Publication
LY1001aDiffuse large-B cell lymphoma tissue array, 100 cases 100 cores, replacing LY1001; ihc Anti-Actin confirmedUS Biomax296 LY1001a Diffuse large-B cell lymphoma tissue array, 100 cases 100 cores, replacing LY1001; ihc Anti-Actin confirmed US Biomax 296
ASK
Publication
BC001111Multiple organ normal and diseased tissue array, 58 cases 60 cores, replaced by MCN601US Biomax231 BC001111 Multiple organ normal and diseased tissue array, 58 cases 60 cores, replaced by MCN601 US Biomax 231
ASK
Publication
BC00111Multiple organ normal and diseased tissue array (replaced by MCN601), 54 cases 60 coresUS Biomax231 BC00111 Multiple organ normal and diseased tissue array (replaced by MCN601), 54 cases 60 cores US Biomax 231
ASK
Publication
MCN601Multiple organ tumor and normal tissue array, 58 cases 60 cores, replaced by MCN602US Biomax231 MCN601 Multiple organ tumor and normal tissue array, 58 cases 60 cores, replaced by MCN602 US Biomax 231
ASK
Publication
BC00115Multiple organ normal and diseased tissue array, 44 cases 64 cores, replaced by MC802US Biomax231 BC00115 Multiple organ normal and diseased tissue array, 44 cases 64 cores, replaced by MC802 US Biomax 231
ASK
Publication
BC00112Multiple organ paired normal and cancer (8 types) tissue array, 48 cases 48 coresUS Biomax160 BC00112 Multiple organ paired normal and cancer (8 types) tissue array, 48 cases 48 cores US Biomax 160
ASK
Publication
BN501Normal human top 10 organ tissue array, 50 cases 50 cores, replacing BN00012 and BN00013US Biomax160 BN501 Normal human top 10 organ tissue array, 50 cases 50 cores, replacing BN00012 and BN00013 US Biomax 160
ASK
Publication
T291aMyeloma tissue array with normal tissue as control, 6 cases 24 cores, replacing T291; ihc Anti-actinUS Biomax114 T291a Myeloma tissue array with normal tissue as control, 6 cases 24 cores, replacing T291; ihc Anti-actin US Biomax 114
ASK
Publication
ME2082aMalignant melanoma tissue array, including TNM and clinical stage, 208 cases 208 cores, replacing ME2082; ihc Anti-Actin confirmedUS Biomax429 ME2082a Malignant melanoma tissue array, including TNM and clinical stage, 208 cases 208 cores, replacing ME2082; ihc Anti-Actin confirmed US Biomax 429
ASK
Publication
EN801aEndocrine cancer tissue array, including TNM and clinical stage, 40 cases 80 cores, replacing EN801; ihc Anti-Actin confirmedUS Biomax296 EN801a Endocrine cancer tissue array, including TNM and clinical stage, 40 cases 80 cores, replacing EN801; ihc Anti-Actin confirmed US Biomax 296
ASK
Publication
PA483aPancreatic cancer tissue array, including TNM and pathology grade, 48 cases 48 cores, replacing PA483; ihc Anti-Actin confirmedUS Biomax185 PA483a Pancreatic cancer tissue array, including TNM and pathology grade, 48 cases 48 cores, replacing PA483; ihc Anti-Actin confirmed US Biomax 185
ASK
Publication
BS17016aBrain glioblastoma tissue array, including pathology grade, 40 cases 80 cores, replacing BS17016; ihc Anti-Actin confirmedUS Biomax267 BS17016a Brain glioblastoma tissue array, including pathology grade, 40 cases 80 cores, replacing BS17016; ihc Anti-Actin confirmed US Biomax 267
ASK
Publication
SO751Leiomyosarcoma and rhabdomyosarcoma tissue array, including TNM and clinical stage, 39 cases 75 cores, replacing BC24021; ihc Anti-Actin confirmedUS Biomax267 SO751 Leiomyosarcoma and rhabdomyosarcoma tissue array, including TNM and clinical stage, 39 cases 75 cores, replacing BC24021; ihc Anti-Actin confirmed US Biomax 267
ASK
Publication
BN243Multiple normal (12 type) tissue array, 12 cases 24 cores, replacing BN241US Biomax88 BN243 Multiple normal (12 type) tissue array, 12 cases 24 cores, replacing BN241 US Biomax 88
ASK
Publication
RAT901Rat multiple organs, normal tissue array, 22 cases 90 cores, replacing BR01013US Biomax231 RAT901 Rat multiple organs, normal tissue array, 22 cases 90 cores, replacing BR01013 US Biomax 231
ASK
Publication
T004Multiple organ cancer and normal tissue array, including TNM and pathology grade, 6 cases 24 coresUS Biomax88 T004 Multiple organ cancer and normal tissue array, including TNM and pathology grade, 6 cases 24 cores US Biomax 88
ASK
Publication
T003Multiple organ cancer and normal tissue array, including TNM and pathology grade, 6 cases 24 coresUS Biomax88 T003 Multiple organ cancer and normal tissue array, including TNM and pathology grade, 6 cases 24 cores US Biomax 88
ASK
Publication
T006Multiple organ cancer and normal tissue array, including TNM and pathology grade, 6 cases 24 coresUS Biomax88 T006 Multiple organ cancer and normal tissue array, including TNM and pathology grade, 6 cases 24 cores US Biomax 88
ASK
Publication
T005Multiple organ cancer and normal tissue array, including TNM and pathology grade, 6 cases 24 coresUS Biomax88 T005 Multiple organ cancer and normal tissue array, including TNM and pathology grade, 6 cases 24 cores US Biomax 88
ASK
Publication
FDA806FDA normal and tumor organ tissue array of human (2 slide set), replacing FDA805, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodiesUS Biomax380 FDA806 FDA normal and tumor organ tissue array of human (2 slide set), replacing FDA805, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies US Biomax 380
ASK
Publication
FDA805FDA normal and tumor organ tissue array of human (2 slide set), replacing FDA804, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodiesUS Biomax314 FDA805 FDA normal and tumor organ tissue array of human (2 slide set), replacing FDA804, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies US Biomax 314
ASK
Publication
TH802aThyroid cancer and adenoma tissue array, including TNM and clinical stage, 80 cases 80 cores, replacing TH802; ihc Anti-Actin confirmedUS Biomax267 TH802a Thyroid cancer and adenoma tissue array, including TNM and clinical stage, 80 cases 80 cores, replacing TH802; ihc Anti-Actin confirmed US Biomax 267
ASK
Publication
T141aPancreas cancer test tissue array, including TNM and pathology grade, 6 cases 24 cores, replacing T141; ihc Anti-Actin confirmedUS Biomax90 T141a Pancreas cancer test tissue array, including TNM and pathology grade, 6 cases 24 cores, replacing T141; ihc Anti-Actin confirmed US Biomax 90
ASK
Publication
T142aPancreas tumor test tissue array, including TNM and pathology grade, 12 cases 24 cores, replacing T142; ihc Anti-Actin confirmedUS Biomax90 T142a Pancreas tumor test tissue array, including TNM and pathology grade, 12 cases 24 cores, replacing T142; ihc Anti-Actin confirmed US Biomax 90
ASK
Publication
T385aMalignant melanoma test tissue array, including TNM and clinical stage, 6 cases 24 cores, replacing T385; ihc Anti-Actin confirmedUS Biomax90 T385a Malignant melanoma test tissue array, including TNM and clinical stage, 6 cases 24 cores, replacing T385; ihc Anti-Actin confirmed US Biomax 90
ASK
Publication
FDA994FDA normal human organ tissue array, 99 cores 33 sites 75 cases, replacing FDA993, replaced by FDA995US Biomax314 FDA994 FDA normal human organ tissue array, 99 cores 33 sites 75 cases, replacing FDA993, replaced by FDA995 US Biomax 314
ASK
Publication
KD961Kidney tumor tissue array with normal tissue as control, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmedUS Biomax258 KD961 Kidney tumor tissue array with normal tissue as control, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed US Biomax 258
ASK
Publication
BC12011aBladder cancer tissue array, including TNM, clinical stage and pathology grade, 63 cases 63 cores, replacing BC12011; ihc Anti-Actin confirmedUS Biomax162 BC12011a Bladder cancer tissue array, including TNM, clinical stage and pathology grade, 63 cases 63 cores, replacing BC12011; ihc Anti-Actin confirmed US Biomax 162
ASK
Publication
T032aLiver tumor tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T032; ihc Anti-Actin confirmedUS Biomax90 T032a Liver tumor tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T032; ihc Anti-Actin confirmed US Biomax 90
ASK
Publication
BR804aBreast cancer tissue array, including TNM, clinical stage and pathology grade, 40 cases 80 cores, replacing BR804; ihc Anti-Actin confirmedUS Biomax267 BR804a Breast cancer tissue array, including TNM, clinical stage and pathology grade, 40 cases 80 cores, replacing BR804; ihc Anti-Actin confirmed US Biomax 267
ASK
Publication
OV803aOvary cancer tissue array, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing OV803; ihc Anti-Actin confirmedUS Biomax258 OV803a Ovary cancer tissue array, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing OV803; ihc Anti-Actin confirmed US Biomax 258
ASK
Publication
PR483aProstate cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores, replacing PR483; ihc Anti-Actin confirmedUS Biomax210 PR483a Prostate cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores, replacing PR483; ihc Anti-Actin confirmed US Biomax 210
ASK
Publication
BR803aBreast cancer tissue array, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing BR803; ihc Anti-Actin confirmedUS Biomax258 BR803a Breast cancer tissue array, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing BR803; ihc Anti-Actin confirmed US Biomax 258
ASK
Publication
ST1004Stomach adenocarcinoma with matched adjacent tissue array, including TNM and pathology grade, 55 cases 100 cores, replacing BC01114; ihc Anti-Actin confirmedUS Biomax258 ST1004 Stomach adenocarcinoma with matched adjacent tissue array, including TNM and pathology grade, 55 cases 100 cores, replacing BC01114; ihc Anti-Actin confirmed US Biomax 258
ASK
Publication
ST483bStomach cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores, replacing ST483; ihc Anti-Actin confirmedUS Biomax210 ST483b Stomach cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores, replacing ST483; ihc Anti-Actin confirmed US Biomax 210
ASK
Publication
PR633Prostate cancer tissue array, including TNM, clinical stage and pathology grade, 63 cases 63 cores, replacing PR8010; ihc Anti-Actin confirmedUS Biomax296 PR633 Prostate cancer tissue array, including TNM, clinical stage and pathology grade, 63 cases 63 cores, replacing PR8010; ihc Anti-Actin confirmed US Biomax 296
ASK
Publication
BC07014aKidney cancer tissue array, including TNM, clinical stage and pathology grade, 72 cases 72 cores, replacing BC07014; ihc Anti-Actin confirmedUS Biomax185 BC07014a Kidney cancer tissue array, including TNM, clinical stage and pathology grade, 72 cases 72 cores, replacing BC07014; ihc Anti-Actin confirmed US Biomax 185
ASK
Publication
LC726aLung cancer tissue array, including TNM, clinical stage and pathology grade, 72 cases 72 cores, replacing LC726; ihc Anti-Actin confirmedUS Biomax228 LC726a Lung cancer tissue array, including TNM, clinical stage and pathology grade, 72 cases 72 cores, replacing LC726; ihc Anti-Actin confirmed US Biomax 228
ASK
Publication
PR803aProstate cancer tissue array, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing PR803; ihc Anti-Actin confirmedUS Biomax296 PR803a Prostate cancer tissue array, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing PR803; ihc Anti-Actin confirmed US Biomax 296
ASK
Publication
BC11012aOvary cancer tissue array, including TNM, clinical stage and pathology grade, 72 cases 72 cores, replacing BC11012; ihc Anti-Actin confirmedUS Biomax185 BC11012a Ovary cancer tissue array, including TNM, clinical stage and pathology grade, 72 cases 72 cores, replacing BC11012; ihc Anti-Actin confirmed US Biomax 185
ASK
Publication
ST483aStomach cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores, replacing ST483; ihc Anti-Actin confirmedUS Biomax185 ST483a Stomach cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores, replacing ST483; ihc Anti-Actin confirmed US Biomax 185
ASK
Publication
T195aProstate cancer test tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T195; ihc Anti-Actin confirmedUS Biomax105 T195a Prostate cancer test tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T195; ihc Anti-Actin confirmed US Biomax 105
ASK
Publication
BR963aBreast disease spectrum tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores, replacing BR963; ihc Anti-Actin confirmedUS Biomax296 BR963a Breast disease spectrum tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores, replacing BR963; ihc Anti-Actin confirmed US Biomax 296
ASK
Publication
T086bBreast cancer test tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T086a; ihc Anti-Actin confirmedUS Biomax90 T086b Breast cancer test tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T086a; ihc Anti-Actin confirmed US Biomax 90
ASK
Publication
HN242aHead and neck cancer tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing HN242; ihc Anti-Actin confirmedUS Biomax90 HN242a Head and neck cancer tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing HN242; ihc Anti-Actin confirmed US Biomax 90
ASK
Publication
T124Bladder cancer test tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T122; ihc Anti-Actin confirmedUS Biomax90 T124 Bladder cancer test tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T122; ihc Anti-Actin confirmed US Biomax 90
ASK
Publication
BC07015Multiple type kidney cancer tissue array with normal tissues, 71 cases 72 cores, replacing BC07012US Biomax231 BC07015 Multiple type kidney cancer tissue array with normal tissues, 71 cases 72 cores, replacing BC07012 US Biomax 231
ASK
Publication
OV802Multiple ovarian carcinoma and normal tissue array, with stage and TNM info, 78 cases 80 cores, replacing BC11011US Biomax231 OV802 Multiple ovarian carcinoma and normal tissue array, with stage and TNM info, 78 cases 80 cores, replacing BC11011 US Biomax 231
ASK
Publication
T086aBreast invasive ductal carcinoma test tissue array, with normal tissue, including TNM and pathology grade, 12 cases 24 cores, replaced by T086b; ihc Anti-Actin confirmedUS Biomax90 T086a Breast invasive ductal carcinoma test tissue array, with normal tissue, including TNM and pathology grade, 12 cases 24 cores, replaced by T086b; ihc Anti-Actin confirmed US Biomax 90
ASK
Publication
BO244aHuman normal bone and osteosarcoma tissue array, including TNM and clinical stage, 12 cases 24 cores; ihc Anti-Actin confirmedUS Biomax105 BO244a Human normal bone and osteosarcoma tissue array, including TNM and clinical stage, 12 cases 24 cores; ihc Anti-Actin confirmed US Biomax 105
ASK
Publication
MC5001High density (495 cases 500 cores) tissue array of multiple organ cancer and normal, with stage and grade information, replaced by MC5002US Biomax634 MC5001 High density (495 cases 500 cores) tissue array of multiple organ cancer and normal, with stage and grade information, replaced by MC5002 US Biomax 634
ASK
Publication
HN483Multiple head and neck cancer with normal tissue array, including TNM and pathology grade, 48 cases 48 cores, replacing HN482US Biomax160 HN483 Multiple head and neck cancer with normal tissue array, including TNM and pathology grade, 48 cases 48 cores, replacing HN482 US Biomax 160
ASK
Publication
MC802Multiple cancer tissue array with matched or unmatched normal control, replacing BC00115, 44 cases 80 cores, with grade informationUS Biomax266 MC802 Multiple cancer tissue array with matched or unmatched normal control, replacing BC00115, 44 cases 80 cores, with grade information US Biomax 266
ASK
Publication
MC483Multiple types of cancer tissue array with normal control, replacing BC00119, 26 cases 48 cores, with stage and grade dataUS Biomax160 MC483 Multiple types of cancer tissue array with normal control, replacing BC00119, 26 cases 48 cores, with stage and grade data US Biomax 160
ASK
Publication
OV1005aOvary disease spectrum (ovarian cancer progression) tissue array, including TNM, clinical stage and pathology grade, 100 cases 100 cores, replacing OV1005; ihc Anti-Actin confirmedUS Biomax267 OV1005a Ovary disease spectrum (ovarian cancer progression) tissue array, including TNM, clinical stage and pathology grade, 100 cases 100 cores, replacing OV1005; ihc Anti-Actin confirmed US Biomax 267
ASK
Publication
MT2081Multiple organ metastatic cancer tissue array, 19 organ 104 cases 208 coresUS Biomax456 MT2081 Multiple organ metastatic cancer tissue array, 19 organ 104 cases 208 cores US Biomax 456
ASK
Publication
LV2091Liver cancer tissue array with normal liver tissue as control, including TNM, clinical stage and pathology grade, 208 cases 208 cores; ihc Anti-Actin confirmedUS Biomax429 LV2091 Liver cancer tissue array with normal liver tissue as control, including TNM, clinical stage and pathology grade, 208 cases 208 cores; ihc Anti-Actin confirmed US Biomax 429
ASK
Publication
PA802Multiple pancreatic cancer tissue array with unmatched normal tissues, with TNM data, 78 cases 80 cores, replacing PA801, to be replaced by PA805US Biomax266 PA802 Multiple pancreatic cancer tissue array with unmatched normal tissues, with TNM data, 78 cases 80 cores, replacing PA801, to be replaced by PA805 US Biomax 266
ASK
Publication
BR1005aBreast cancer and matched metastatic carcinoma of lymph node tissue array, including TNM, clinical stage and pathology grade, 50 cases 100 cores, replacing BR1005; ihc Anti-Actin confirmedUS Biomax296 BR1005a Breast cancer and matched metastatic carcinoma of lymph node tissue array, including TNM, clinical stage and pathology grade, 50 cases 100 cores, replacing BR1005; ihc Anti-Actin confirmed US Biomax 296
ASK
Publication
PR956Prostate cancer tissue array with matched normal adjacent tissue and metastatic bones, with TNM, Gleason scores, PSA level and survival data, 40 cases 95 cores, replacing PR955; ihc Anti-Actin confirUS Biomax487 PR956 Prostate cancer tissue array with matched normal adjacent tissue and metastatic bones, with TNM, Gleason scores, PSA level and survival data, 40 cases 95 cores, replacing PR955; ihc Anti-Actin confir US Biomax 487
ASK
Publication
ES481Esophageal cancer tissue array with matched or unmatched normal adjacent tissues (18 cases 48 cores) with stage and grade info; ihc Anti-Actin confirmedUS Biomax210 ES481 Esophageal cancer tissue array with matched or unmatched normal adjacent tissues (18 cases 48 cores) with stage and grade info; ihc Anti-Actin confirmed US Biomax 210
ASK
Publication
MC245Multiple cancer (12 type) and adjacent normal tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing MC242US Biomax88 MC245 Multiple cancer (12 type) and adjacent normal tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing MC242 US Biomax 88
ASK
Publication
BR243cBreast cancer tissue array with matched adjacent normal breast tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replaced by BR243d; ihc Anti-Actin confirmedUS Biomax90 BR243c Breast cancer tissue array with matched adjacent normal breast tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replaced by BR243d; ihc Anti-Actin confirmed US Biomax 90
ASK
Publication
FMS151Brains of multiple species frozen tissue array, 14 cases 15 coresUS Biomax293 FMS151 Brains of multiple species frozen tissue array, 14 cases 15 cores US Biomax 293
ASK
Publication
FMS152Liver of multiple species frozen tissue array, 14 cases 15 coresUS Biomax293 FMS152 Liver of multiple species frozen tissue array, 14 cases 15 cores US Biomax 293
ASK
Publication
PR807aProstate cancer, hyperplasia and normal tissue array, including TNM and pathology grade, 79 cases 80 cores, replacing PR807; ihc Anti-Prostate Specific Antigen (PSA) confirmedUS Biomax296 PR807a Prostate cancer, hyperplasia and normal tissue array, including TNM and pathology grade, 79 cases 80 cores, replacing PR807; ihc Anti-Prostate Specific Antigen (PSA) confirmed US Biomax 296
ASK
Publication
ME1004aMalignant melanoma, metastatic malignant melanoma and nevus tissue array, including TNM and clinical stage, 100 cases 100 cores, replacing ME1004; ihc Anti-Actin confirmedUS Biomax296 ME1004a Malignant melanoma, metastatic malignant melanoma and nevus tissue array, including TNM and clinical stage, 100 cases 100 cores, replacing ME1004; ihc Anti-Actin confirmed US Biomax 296
ASK
Publication
BN481Multiple human normal organ (12 type) tissue microarray, 24 cases 48 coresUS Biomax160 BN481 Multiple human normal organ (12 type) tissue microarray, 24 cases 48 cores US Biomax 160
ASK
Publication
BN00112Multiple organ normal tissue array, 40cases 40 cores, replaced by BN00119US Biomax160 BN00112 Multiple organ normal tissue array, 40cases 40 cores, replaced by BN00119 US Biomax 160
ASK
Publication
BC000111Multiple organ cancer tissue array, 39 cases 39 coresUS Biomax189 BC000111 Multiple organ cancer tissue array, 39 cases 39 cores US Biomax 189
ASK
Publication
BCN801Multiple organ cancer with adjacent tissue combined panel tissue array, 48 cases 80 coresUS Biomax231 BCN801 Multiple organ cancer with adjacent tissue combined panel tissue array, 48 cases 80 cores US Biomax 231
ASK
Publication
PA805Pancreatic cancer tissue array, with adjacent normal tissue and normal tissue, including TNM and pathology grade, 80 cases 80 cores, replacing PA802US Biomax266 PA805 Pancreatic cancer tissue array, with adjacent normal tissue and normal tissue, including TNM and pathology grade, 80 cases 80 cores, replacing PA802 US Biomax 266
ASK
Publication
BR8015Breast cancer tissue array, with adjacent normal tissue and normal tissue, including TNM and pathology grade, 80 cases 80 cores, replacing BC08014US Biomax231 BR8015 Breast cancer tissue array, with adjacent normal tissue and normal tissue, including TNM and pathology grade, 80 cases 80 cores, replacing BC08014 US Biomax 231
ASK
Publication
BR2085cBreast cancer tissue array, with normal tissue and adjacent normal tissue, including TNM and pathology grade, 188 cases 208 cores, replacing BR2085aUS Biomax456 BR2085c Breast cancer tissue array, with normal tissue and adjacent normal tissue, including TNM and pathology grade, 188 cases 208 cores, replacing BR2085a US Biomax 456
ASK
Publication
MT801Multiple organ cancer metastasis tissue array, 80 cases 80 coresUS Biomax266 MT801 Multiple organ cancer metastasis tissue array, 80 cases 80 cores US Biomax 266
ASK
Publication
AC451Multiple organ condyloma acuminatum tissue array, 45 cases 45 coresUS Biomax331 AC451 Multiple organ condyloma acuminatum tissue array, 45 cases 45 cores US Biomax 331
ASK
Publication
FCO401Colorectal organ carcinoma frozen tissue array, including TNM, clinical stage, 40 cases 40 cores, replaced by FCO401aUS Biomax293 FCO401 Colorectal organ carcinoma frozen tissue array, including TNM, clinical stage, 40 cases 40 cores, replaced by FCO401a US Biomax 293
ASK
Publication
T205Lymphoma tissue array, 6 cases 24 cores; ihc Anti-Actin confirmedUS Biomax90 T205 Lymphoma tissue array, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90
ASK
Publication
ON481Oncocytoma tissue array, 24 cases 48 cores; ihc Anti-Actin confirmedUS Biomax162 ON481 Oncocytoma tissue array, 24 cases 48 cores; ihc Anti-Actin confirmed US Biomax 162
ASK
Publication
SF961Soft tissue tumor tissue array, including TNM and clinical stage, 48 cases 96 cores; ihc Anti-Actin confirmedUS Biomax228 SF961 Soft tissue tumor tissue array, including TNM and clinical stage, 48 cases 96 cores; ihc Anti-Actin confirmed US Biomax 228
ASK
Publication
MC484Multiple organs tumor and normal adjacent tissue, replacing BC00113, 44 cases 48 coresUS Biomax160 MC484 Multiple organs tumor and normal adjacent tissue, replacing BC00113, 44 cases 48 cores US Biomax 160
ASK
Publication
BC00014Multiple organ diseased tissue array, 63 cases 63 cores, replaced by MC631US Biomax160 BC00014 Multiple organ diseased tissue array, 63 cases 63 cores, replaced by MC631 US Biomax 160
ASK
Publication
BC00012Multiple organ diseased tissue array, 30 cases 60 cores, replaced by MC801US Biomax160 BC00012 Multiple organ diseased tissue array, 30 cases 60 cores, replaced by MC801 US Biomax 160
ASK
Publication
BC00119Multiple organ diseased tissue array, 32 cases 32 cores, replaced by MC483US Biomax160 BC00119 Multiple organ diseased tissue array, 32 cases 32 cores, replaced by MC483 US Biomax 160
ASK
Publication
BC00019Multiple organ squamous cell carcinoma tissue array, 63 cases 63 coresUS Biomax231 BC00019 Multiple organ squamous cell carcinoma tissue array, 63 cases 63 cores US Biomax 231
ASK
Publication
FCO401aFrozen colorectal adenocarcinoma tissue array, including TNM and clinical stage, 40 cases 40 cores, replacing FCO401US Biomax781 FCO401a Frozen colorectal adenocarcinoma tissue array, including TNM and clinical stage, 40 cases 40 cores, replacing FCO401 US Biomax 781
ASK
Publication
BCN961Multiple organ cancer tissue array with adjacent cancer tissue control tissue array, 57 cases 96 cores, replaced by BCN963US Biomax231 BCN961 Multiple organ cancer tissue array with adjacent cancer tissue control tissue array, 57 cases 96 cores, replaced by BCN963 US Biomax 231
ASK
Publication
BCN962Combined multiple normal and cancer tissue array, containing germline, embryonic tumors and normal adjacent tissue, 60 cases 96 coresUS Biomax231 BCN962 Combined multiple normal and cancer tissue array, containing germline, embryonic tumors and normal adjacent tissue, 60 cases 96 cores US Biomax 231
ASK
Publication
T244Soft tissue malignant tumor tissue array, including TNM and clinical stage, 6 cases 24 cores; ihc Anti-Actin confirmedUS Biomax90 T244 Soft tissue malignant tumor tissue array, including TNM and clinical stage, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90
ASK
Publication
T388Malignant melanoma test tissue array (4x (2x3)array), including TNM and clinical stage, 6 cases 24 cores; ihc Anti-Actin confirmedUS Biomax90 T388 Malignant melanoma test tissue array (4x (2x3)array), including TNM and clinical stage, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90
ASK
Publication
MC8010Multiple organ cancer tissue array, including TNM and pathology grade, 80 cases 80 coresUS Biomax278 MC8010 Multiple organ cancer tissue array, including TNM and pathology grade, 80 cases 80 cores US Biomax 278
ASK
Publication
GI101Multiple organ gastrointestinal (GI) tract cancer metastasis tissue array, 50 cases 100 coresUS Biomax266 GI101 Multiple organ gastrointestinal (GI) tract cancer metastasis tissue array, 50 cases 100 cores US Biomax 266
ASK
Publication
LV487Hepatocellular carcinoma tissue array with matched liver adjacent tissue, including TNM and pathology grade, 16 cases 48 cores,; ihc Anti-Actin confirmedUS Biomax185 LV487 Hepatocellular carcinoma tissue array with matched liver adjacent tissue, including TNM and pathology grade, 16 cases 48 cores,; ihc Anti-Actin confirmed US Biomax 185
ASK
Publication
MC541Multiple organ, diseased tissue array (54 cases 54 cores, 18 types of cancers), replaced by MC542US Biomax160 MC541 Multiple organ, diseased tissue array (54 cases 54 cores, 18 types of cancers), replaced by MC542 US Biomax 160
ASK
Publication
T095Endometrium cancer test tissue array (4x (2x3)array), including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmedUS Biomax90 T095 Endometrium cancer test tissue array (4x (2x3)array), including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90
ASK
Publication
T046Lung cancer test tissue array (4x (2x3)array) including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmedUS Biomax90 T046 Lung cancer test tissue array (4x (2x3)array) including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90
ASK
Publication
T014Stomach cancer test tissue array (4x (2x3)array), including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmedUS Biomax90 T014 Stomach cancer test tissue array (4x (2x3)array), including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90
ASK
Publication
T024Esophageal cancer test tissue array (4x (2x3)array), including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmedUS Biomax90 T024 Esophageal cancer test tissue array (4x (2x3)array), including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90
ASK
Publication
T034Liver cancer test tissue array (4x (2x3) array) including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmedUS Biomax90 T034 Liver cancer test tissue array (4x (2x3) array) including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90
ASK
Publication
T089Breast cancer test tissue array (4x (2x3)array), including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmedUS Biomax90 T089 Breast cancer test tissue array (4x (2x3)array), including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90
ASK
Publication
T074Kidney cancer test tissue array (4x (2x3)array), including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmedUS Biomax90 T074 Kidney cancer test tissue array (4x (2x3)array), including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90
ASK
Publication
VLC12Lung cancer tissue array, with TNM and grade info, 12 cases 12 cores; ihc Anti-Actin confirmedUS Biomax105 VLC12 Lung cancer tissue array, with TNM and grade info, 12 cases 12 cores; ihc Anti-Actin confirmed US Biomax 105
ASK
Publication
MNO661Normal organ tissue array of human, 66 cases 66 coresUS Biomax189 MNO661 Normal organ tissue array of human, 66 cases 66 cores US Biomax 189
ASK
Publication
MC485Multiple organ tumor tissue array, including TNM, clinical stage and pathology grade, 24 cases 48 coresUS Biomax231 MC485 Multiple organ tumor tissue array, including TNM, clinical stage and pathology grade, 24 cases 48 cores US Biomax 231
ASK
Publication
MC2082Multiple organ tumor tissue array, including TNM, clinical stage and pathology grade, 208 cases 208 coresUS Biomax456 MC2082 Multiple organ tumor tissue array, including TNM, clinical stage and pathology grade, 208 cases 208 cores US Biomax 456
ASK
Publication
CO804Multiple types of colon carcinoma tissue array (replacing BC05011), 80 cases 80 coresUS Biomax231 CO804 Multiple types of colon carcinoma tissue array (replacing BC05011), 80 cases 80 cores US Biomax 231
ASK
Publication
MC801Multiple cancer tissue array, replacing BC00012, 80 cases 80 cores, with grade informationUS Biomax266 MC801 Multiple cancer tissue array, replacing BC00012, 80 cases 80 cores, with grade information US Biomax 266
ASK
Publication
LC806Multiple types of lung carcinoma tissue array, 80 cases 80 cores, replacing BC04013US Biomax231 LC806 Multiple types of lung carcinoma tissue array, 80 cases 80 cores, replacing BC04013 US Biomax 231
ASK
Publication
T176Brain tumor tissue array, including pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmedUS Biomax90 T176 Brain tumor tissue array, including pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90
ASK
Publication
ST1503Stomach adenocarcinoma tissue array, including TNM and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmedUS Biomax258 ST1503 Stomach adenocarcinoma tissue array, including TNM and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed US Biomax 258
ASK
Publication
T047Non-small cell lung cancer test tissue array (4x (2x3)array) including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmedUS Biomax90 T047 Non-small cell lung cancer test tissue array (4x (2x3)array) including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90
ASK
Publication
RhFDA1FDA normal organ tissue array of rhesus monkey, 99 cases 99 coresUS Biomax278 RhFDA1 FDA normal organ tissue array of rhesus monkey, 99 cases 99 cores US Biomax 278
ASK
Publication
CyFDAFDA normal organ tissue array of cynomolgus monkey, 99 cases 99 coresUS Biomax314 CyFDA FDA normal organ tissue array of cynomolgus monkey, 99 cases 99 cores US Biomax 314
ASK
Publication
LC817Lung cancer tissue array with matched lymph node metastatic tissue, including TNM, clinical stage and pathology grade, 40 cases 80 cores; ihc Anti-Actin confirmedUS Biomax258 LC817 Lung cancer tissue array with matched lymph node metastatic tissue, including TNM, clinical stage and pathology grade, 40 cases 80 cores; ihc Anti-Actin confirmed US Biomax 258
ASK
Publication
CR1001Multiple uterine carcinoma tissue array with normal tissue, 49 cases 100 coresUS Biomax231 CR1001 Multiple uterine carcinoma tissue array with normal tissue, 49 cases 100 cores US Biomax 231
ASK
Publication
HN801Multiple head and neck tumor tissue array with normal tissue, 40 cases 80 coresUS Biomax266 HN801 Multiple head and neck tumor tissue array with normal tissue, 40 cases 80 cores US Biomax 266
ASK
Publication
T002Endocrine organ cancer test tissue array, with normal tissue as control, including TNM and clinical stage, 6 cases 24 coresUS Biomax88 T002 Endocrine organ cancer test tissue array, with normal tissue as control, including TNM and clinical stage, 6 cases 24 cores US Biomax 88
ASK
Publication
FDA997FDA normal organ tissue array of human, 47 cases 99 cores, for FDA guidelines to test tissue specificity of antibodies, replaced by FDA998US Biomax314 FDA997 FDA normal organ tissue array of human, 47 cases 99 cores, for FDA guidelines to test tissue specificity of antibodies, replaced by FDA998 US Biomax 314
ASK
Publication
BL802Bladder cancer tissue array with normal tissue, 80 cases 80 cores, replacing BC12012US Biomax266 BL802 Bladder cancer tissue array with normal tissue, 80 cases 80 cores, replacing BC12012 US Biomax 266
ASK
Publication
KD804Multiple types of kidney cancer and normal, adjacent normal tissue array, 80 cases 80 cores, with stage and grade informationUS Biomax231 KD804 Multiple types of kidney cancer and normal, adjacent normal tissue array, 80 cases 80 cores, with stage and grade information US Biomax 231
ASK
Publication
SK482Multiple skin cancer tissue array with 4 normal tissue control from autopsy, 24 cases 48 coresUS Biomax160 SK482 Multiple skin cancer tissue array with 4 normal tissue control from autopsy, 24 cases 48 cores US Biomax 160
ASK
Publication
PA242Multiple pancreatic cancer tissue array with unmatched normal adjacent tissue, 12 cases 24 coresUS Biomax88 PA242 Multiple pancreatic cancer tissue array with unmatched normal adjacent tissue, 12 cases 24 cores US Biomax 88